OPKO Health EBITDA 2010-2024 | OPK
OPKO Health ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| OPKO Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-51 |
| 2022 | $-116 |
| 2021 | $98 |
| 2020 | $144 |
| 2019 | $-179 |
| 2018 | $-74 |
| 2017 | $-174 |
| 2016 | $0 |
| 2015 | $-55 |
| 2014 | $-129 |
| 2013 | $-63 |
| 2012 | $-27 |
| 2011 | $-19 |
| 2010 | $-9 |
| 2009 | $-22 |
| OPKO Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $39 |
| 2024-06-30 | $-37 |
| 2024-03-31 | $-45 |
| 2023-12-31 | $-43 |
| 2023-09-30 | $-38 |
| 2023-06-30 | $34 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-29 |
| 2022-09-30 | $-61 |
| 2022-06-30 | $18 |
| 2022-03-31 | $-44 |
| 2021-12-31 | $-44 |
| 2021-09-30 | $57 |
| 2021-06-30 | $26 |
| 2021-03-31 | $59 |
| 2020-12-31 | $70 |
| 2020-09-30 | $43 |
| 2020-06-30 | $50 |
| 2020-03-31 | $-19 |
| 2019-12-31 | $-89 |
| 2019-09-30 | $-15 |
| 2019-06-30 | $-24 |
| 2019-03-31 | $-51 |
| 2018-12-31 | $-66 |
| 2018-09-30 | $-9 |
| 2018-06-30 | $20 |
| 2018-03-31 | $-18 |
| 2017-12-31 | $-132 |
| 2017-09-30 | $-22 |
| 2017-06-30 | $-0 |
| 2017-03-31 | $-19 |
| 2016-12-31 | $-50 |
| 2016-09-30 | $2 |
| 2016-06-30 | $53 |
| 2016-03-31 | $-5 |
| 2015-12-31 | $14 |
| 2015-09-30 | $4 |
| 2015-06-30 | $-21 |
| 2015-03-31 | $-53 |
| 2014-12-31 | $-29 |
| 2014-09-30 | $-44 |
| 2014-06-30 | $-29 |
| 2014-03-31 | $-27 |
| 2013-12-31 | $-31 |
| 2013-09-30 | $-15 |
| 2013-06-30 | $-14 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-7 |
| 2012-09-30 | $-7 |
| 2012-06-30 | $-7 |
| 2012-03-31 | $-7 |
| 2011-12-31 | $-8 |
| 2011-09-30 | $-5 |
| 2011-06-30 | $-4 |
| 2011-03-31 | $-3 |
| 2010-12-31 | $3 |
| 2010-09-30 | $-4 |
| 2010-06-30 | $-5 |
| 2010-03-31 | $-3 |
| 2009-12-31 | $-3 |
| 2009-09-30 | $-5 |
| 2009-06-30 | $-5 |
| 2009-03-31 | $-8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.085B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.393B | 24.93 |
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| Waters (WAT) | United States | $22.876B | 33.83 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| Integra LifeSciences Holdings (IART) | United States | $1.864B | 9.74 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |